New breakthrough could help treat muscular dystrophy

By Raquel Maurier
U of A medical researcher Toshifumi Yokota used a new drug cocktail to lessen the severity of Duchenne muscular dystrophy symptoms in lab models.

A researcher in the Faculty of Medicine & Dentistry at the University of Alberta improved Duchenne muscular dystrophy symptoms in non-human lab models, using a new drug cocktail. The drug combination targets the “hot spot” of the gene mutation, making the condition less severe.

Toshifumi Yokota, the study’s principal investigator, published his findings Aug. 6 in the peer-reviewed journal, Proceedings of the National Academy of Sciences. He is a researcher in the Department of Medical Genetics and holds two research chairs: The Friends of Garrett Cumming Research Chair, Canada; and the H.M. Toupin Neurological Science Chair.

Yokota has worked on this research for more than five years. He is now using the same on human cells with Duchenne muscular dystrophy and hopes to see similar results.

Duchenne muscular dystrophy, one of the most common genetic disorders, is caused by a lack of dystrophin, a muscle-supporting protein. In the lab, the drug cocktail improved normal functioning of the mutated gene that triggers the condition. The therapy allowed the lab models to produce 10 per cent to 15 per cent normal levels of dystrophin.

“With this drug cocktail, we were able to target the hot-spot mutated parts of the gene,” said Yokota. “The results were very good—better than we expected. The Duchenne muscular dystrophy condition was less severe.”

Yokota noted that about half of those living with Duchenne could potentially benefit from the drug cocktail, once further testing is conducted and clinical trials are completed.

He worked with colleagues in the United States and Japan on the findings.

Related Stories

Researchers review muscular dystrophy therapies

date Jun 22, 2012

Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy ...

Recommended for you

A high-fat diet may alleviate mitochondrial disease

date 1 hour ago

Mice that have a genetic version of mitochondrial disease can easily be mistaken for much older animals by the time they are nine months old: they have thinning grey hair, osteoporosis, poor hearing, infertility, ...

Cheek muscles hold up better than leg muscles in space

date 1 hour ago

It is well known that muscles need resistance (gravity) to maintain optimal health, and when they do not have this resistance, they deteriorate. A new report published in the July 2015 issue of The FASEB Journal, however, sugges ...

Sialic acid: A key to unlocking brain disorders

date 4 hours ago

A new report published in the July 2015 issue of The FASEB Journal suggests that a common molecule found in higher animals, including humans, affects brain structure. This molecule may play a significant role in how brain ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.